Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujing Xu

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Molecules (Basel, Switzerland)|December 11, 2022
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid ModulatorsShujing Xu, Lin Sun, Waleed A Zalloum, et al.
Journal of Medicinal Chemistry|May 6, 2026
Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and HyperuricemiaQian Yang, Danhui Qi, Wenjie Ye, et al.
RSC Medicinal Chemistry|July 24, 2023
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Signal Transduction and Targeted Therapy|May 18, 2026
Myeloid Mas drives pyruvate kinase M2-mediated Spi1 lactylation to fuel inflammatory senescence in MASLDLuying Zhao, Shujing Xu, Shikai Qiao, et al.
Journal of Medicinal Chemistry|October 17, 2024
"Pseudosubstrate Envelope"/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand EfficiencyShujing Xu, Shuo Wang, Yang Zhou, et al.
Journal of Medical Virology|August 10, 2022
Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid proteinXiangyi Jiang, Prem Prakash Sharma, Brijesh Rathi, et al.
European Journal of Medicinal Chemistry|September 30, 2021
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitorsXujie Zhang, Lin Sun, Megan E Meuser, et al.
Bioorganic Chemistry|October 20, 2022
Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulatorsShuo Wang, Yujie Ren, Qilan Li, et al.
European Journal of Medicinal Chemistry|July 3, 2022
Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitorsLina Zhang, Fenju Wei, David Borrego, et al.
Journal of Medicinal Chemistry|March 14, 2024
Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable DruggabilityXiaoyu Shi, Tong Zhao, Shuo Wang, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Molecules (Basel, Switzerland)|December 11, 2022
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid ModulatorsShujing Xu, Lin Sun, Waleed A Zalloum, et al.
Journal of Medicinal Chemistry|May 6, 2026
Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and HyperuricemiaQian Yang, Danhui Qi, Wenjie Ye, et al.
RSC Medicinal Chemistry|July 24, 2023
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Signal Transduction and Targeted Therapy|May 18, 2026
Myeloid Mas drives pyruvate kinase M2-mediated Spi1 lactylation to fuel inflammatory senescence in MASLDLuying Zhao, Shujing Xu, Shikai Qiao, et al.
Journal of Medicinal Chemistry|October 17, 2024
"Pseudosubstrate Envelope"/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand EfficiencyShujing Xu, Shuo Wang, Yang Zhou, et al.
Journal of Medical Virology|August 10, 2022
Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid proteinXiangyi Jiang, Prem Prakash Sharma, Brijesh Rathi, et al.
European Journal of Medicinal Chemistry|September 30, 2021
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitorsXujie Zhang, Lin Sun, Megan E Meuser, et al.
Bioorganic Chemistry|October 20, 2022
Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulatorsShuo Wang, Yujie Ren, Qilan Li, et al.
European Journal of Medicinal Chemistry|July 3, 2022
Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitorsLina Zhang, Fenju Wei, David Borrego, et al.
Journal of Medicinal Chemistry|March 14, 2024
Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable DruggabilityXiaoyu Shi, Tong Zhao, Shuo Wang, et al.
Pageof 11